Abstract
Movement disorders are a group of syndromes which includes parkinsonism, chorea, dystonia, myoclonus, tremor, and tics. Many of the diseases of this group manifest disturbances of gait and posture along with other abnormalities. Parkinsonism is characterized by rest tremor, muscular rigidity, bradykinesia, flexed posture of the trunk, and loss of postural reflexes. Parkinson’s disease (PD) is the most prevalent of the diseases of this group and patients usually manifest problems of gait and posture in late phases. On the other hand, atypical parkinsonism diseases (multiple-system atrophy, progressive supranuclear palsy, dementia with Lewy bodies, and corticobasal ganglionic degeneration) manifest gait problems and falls very early and are much more incapacitating than PD. Vascular parkinsonism manifests itself with lower limb rigidity and bradykinesia and affects gait very early. Huntington’s disease is a genetic disorder characterized by behavioral and cognitive disturbances associated with chorea, dystonia, and loss of equilibrium. Sometimes, especially in subjects with the juvenile form of Huntington’s disease, it may manifest with a very severe parkinsonism.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fahn S, Jankovic J. Principle and practice of movement disorders. Philadelphia: Churchill Livingstone; 2007. p. 652.
Campbell WW. DeJong’s. The neurologic examination. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.
Jellinger KA. Neuropathological spectrum of synucleinopathies. Mov Disord. 2003;18 suppl 6:S2–12.
Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386:896–912.
Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson’s disease: a baseline analysis of the DATATOP cohort. Neurology. 1990;41:1529–34.
Connolly BS, Lang AE. Pharmacological treatment of Parkinson’s disease. A review. JAMA. 2014;311:1670–83.
Wagle Shukla A, Okun MS. Surgical treatment of Parkinson’s disease: patients, targets, devices, and approaches. Neurotherapeutics. 2014;11:47–59.
Fanciulli A, Wenning GK. Multiple-system atrophy. N Engl J Med. 2015;372:249–63.
Golbe LI. Progressive supranuclear palsy. Semin Neurol. 2014;34:151–9.
Walker Z, Possin KL, Boeve BF, Aarsland D. Lewy body dementias. Lancet. 2015;386:1683–94.
Benítez-Rivero S, Lama MJ, Huertas-Fernández I, et al. Clinical features and neuropsychological profile in vascular parkinsonism. J Neurol Sci. 2014;345:193–7.
Vale TC, Caramelli P, Cardoso F. Clinicoradiological comparison between vascular parkinsonism and Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2015;86(5):547–53.
Wang HC, Hsu JL, Leemans A. Diffusion tensor imaging of vascular parkinsonism: structural changes in cerebral white matter and the association with clinical severity. Arch Neurol. 2012;69:1340–8.
FitzGerald PM, Jankovic J. Lower body parkinsonism: evidence for vascular etiology. Mov Disord. 1989;4:249–60.
Constantinescu R, Richard I, Kurlan R. Levodopa responsiveness in disorders with parkinsonism: a review of the literature. Mov Disord. 2007;22:2141–8.
Wheeler VC, Persichetti F, McNeil SM, et al. Factors associated with HD CAG repeat instability in Huntington disease. J Med Genet. 2007;44:695–701.
Tabrizi SJ, Langbehn DR, Leavitt BR, TRACK-HD Investigators, et al. Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 2009;8:791–801.
Cardoso F. Huntington disease and other choreas. Neurol Clin. 2009;27:719–36.
Andrew SE, Goldberg YP, Kremer B, Telenius H, et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington’s disease. Nat Genet. 1993;4:398–403.
Morreale MK. Huntington’s disease: looking beyond the movement disorder. Adv Psychosom Med. 2015;34:135–42.
Bonelli RM, Hoffman P. A systematic review of the treatment studies in Huntington’s disease since 1990. Expert Opin Pharmacother. 2007;8:141–53.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Ferraz, H.B., Saba, R.A. (2017). Clinical Aspects of Movement Disorders: Effects on Walking and Posture. In: Barbieri, F., Vitório, R. (eds) Locomotion and Posture in Older Adults. Springer, Cham. https://doi.org/10.1007/978-3-319-48980-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-48980-3_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-48979-7
Online ISBN: 978-3-319-48980-3
eBook Packages: MedicineMedicine (R0)